SYNTHOMER PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 280.5 GBX | -6.66% |
|
-7.12% | +47.87% |
| Sales 2024 * | 1.99B 2.53B 3.47B | Sales 2025 * | 2.17B 2.76B 3.79B | Capitalization | 492M 625M 857M |
|---|---|---|---|---|---|
| Net income 2024 * | -28M -35.59M -48.8M | Net income 2025 * | 9M 11.44M 15.69M | EV / Sales 2024 * | 0.51 x |
| Net Debt 2024 * | 524M 666M 913M | Net Debt 2025 * | 484M 615M 843M | EV / Sales 2025 * | 0.45 x |
| P/E ratio 2024 * |
-14
x | P/E ratio 2025 * |
49.7
x | Employees | 4,200 |
| Yield 2024 * |
-
| Yield 2025 * |
0.71% | Free-Float | 66.02% |
More Fundamentals
* Assessed data
More news
Latest transcript on Synthomer plc
More press releases
More news
| 1 day | -5.07% | ||
| 1 week | -7.12% | ||
| Current month | +7.88% | ||
| 1 month | +12.20% | ||
| 3 months | +92.52% | ||
| 6 months | +57.76% | ||
| Current year | +47.87% |
1 week
280.50
312.50
1 month
250.00338.00
Current year
118.00338.00
1 year
118.002 004.00
3 years
118.0011 410.00
5 years
118.0011 410.00
10 years
118.0011 610.00
| Managers | Title | Age | Since |
|---|---|---|---|
Michael Willome
CEO | Chief Executive Officer | 58 | 21-10-31 |
Lily Liu
DFI | Director of Finance/CFO | 52 | 22-06-30 |
Jan Chalmovsky
PRN | Corporate Officer/Principal | - | 22-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ian Tyler
BRD | Director/Board Member | 62 | 22-06-20 |
Alexander Catto
BRD | Director/Board Member | 71 | 80-12-31 |
| Chairman | 64 | 15-03-19 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 746 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - | |
| 0.00% | 45 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-29 | 280.5 | -6.66% | 479 817 |
| 24-05-28 | 300.5 | -1.80% | 364,339 |
| 24-05-24 | 306 | +4.97% | 474,131 |
| 24-05-23 | 291.5 | -3.48% | 361,429 |
| 24-05-22 | 302 | -4.43% | 213,901 |
Delayed Quote London S.E., May 29, 2024 at 11:35 am
More quotes
Synthomer plc is a supplier of specialty polymers and ingredients for coatings, construction, adhesives, and healthcare end markets. The Companyâs segments include Coatings & Construction Solutions (CCS), Adhesive Solutions (AS), and Health & Protection and Performance Materials (HPPM). Its CCS segment offers a range of coatings and construction products. It works across architectural and masonry coatings, mortar modification, waterproofing and flooring, fiber bonding, and energy solutions. Its adhesive solutions bond, modify and components for products including tapes and labels, packaging, hygiene, tires and plastic modification, helping improve permeability, strength, elasticity, damping, dispersion and grip. Its HPPM segment the Company offers water-based polymers for medical gloves, and a European manufacturer of high-performance binders, foams and other products serving customers in a range of end markets. It operates 30 manufacturing sites across Europe, North America and Asia.
Sector
Specialty Chemicals
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
3.005
GBP
Average target price
3.031
GBP
Spread / Average Target
+0.87%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +47.87% | 628M | |
| +14.35% | 65.37B | |
| +0.47% | 48.63B | |
| +20.87% | 42.74B | |
| +26.01% | 27.7B | |
| +8.88% | 19.15B | |
| -4.51% | 16.52B | |
| +7.89% | 16.29B | |
| -28.97% | 15.21B | |
| -13.92% | 15.02B |
- Stock Market
- Equities
- SYNT Stock
